We found that rhMG53 could enhance plasma membrane repair in ex vivo brain slices from APP/PS1 mice (Figure 1), primary rat neurons treated with recombinant Aβ42, and N2A cells treated with AD patient CSF (Figure 2). This evidence concerns the gene APP and Alzheimer disease.